EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advancing Epidermal Barrier Resilience in Atopic Dermatitis with Isosorbide Di-Fatty Acid Esters: From Disruption to Restoration

Ratan K Chaudhuri, Raja K Sivamani iD

Biomolecules · 2026

DOI: 10.3390/biom16091246 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von Ratan K Chaudhuri und 1 weiteren Autor:innen. Beteiligte Einrichtung: CuralysMD Dermaceuticals, A Hallstar Company, 10 Waterview Blvd, Parsippany, NJ 07054, USA. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Epidermis, Isosorbide, Esters. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease characterized by epidermal barrier dysfunction, immune dysregulation, microbial imbalance, and severe pruritus. Emerging evidence establishes that barrier disruption is a central pathogenic driver capable of initiating inflammatory signaling, neuroimmune activation, and chronic disease instability. This understanding has shifted therapeutic paradigms toward barrier-directed strategies aimed at restoring epidermal resilience. This narrative review evaluates the mechanistic and clinical evidence surrounding isosorbide fatty acid diester molecules—specifically isosorbide dicaprylate (IDC) and isosorbide di-(linoleate/oleate) (IDL)—as a barrier-first approach for AD management. Early in vitro and ex vivo investigations demonstrated that IDC significantly improves epidermal hydration, transepidermal water loss, and the expression of barrier-associated genes linked to epidermal integrity. Subsequent studies showed that IDL expands these effects through coordinated regulation of keratinocyte differentiation, lipid homeostasis, and inflammatory stress pathways. Furthermore, recent mechanistic data highlight synergistic anti-inflammatory and pruritus-modulating effects involving TRPA1-, TRPV3-, and TSLP-associated pathways, while preserving tissue integrity under cytokine-induced stress. Clinically, these findings are supported by randomized studies in pediatric and adult cohorts demonstrating significant reductions in pruritus, favorable Eczema Area and Severity Index (EASI) responses, decreased topical corticosteroid dependence, and a reduction in the relative abundance of Staphylococcus aureus. Collectively, these findings support a barrier-first therapeutic framework in which restoration of epidermal resilience may beneficially influence multiple interconnected pathways involved in atopic dermatitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicEpidermisIsosorbideEstersHumansAnimalsPruritus

Stichwörter der Autor:innen

atopic dermatitisepidermal barrierisosorbide fatty acid diestersmicrobiomepruritus signalingskin resilience

Substanzen

IsosorbideEsters

Autor:innen und Institutionen

  • CuralysMD Dermaceuticals, A Hallstar Company, 10 Waterview Blvd, Parsippany, NJ 07054, USA.
  • Integrative Skin Science and Research, Sacramento, CA 95815, USA.
  • Integrative Research Institute, 4825 J Street, Suite 100, Sacramento, CA 95819, USA.
  • College of Medicine, California Northstate University, Elk Grove, CA 95757, USA.
  • Pacific Skin Institute, Sacramento, CA 95815, USA.

ORCID-Profile: Raja K Sivamani

Zitieren

APA

Chaudhuri, R. K., & Sivamani, R. K. (2026). Advancing Epidermal Barrier Resilience in Atopic Dermatitis with Isosorbide Di-Fatty Acid Esters: From Disruption to Restoration. Biomolecules. https://doi.org/10.3390/biom16091246

Vancouver

Chaudhuri RK, Sivamani RK. Advancing Epidermal Barrier Resilience in Atopic Dermatitis with Isosorbide Di-Fatty Acid Esters: From Disruption to Restoration. Biomolecules. 2026. doi:10.3390/biom16091246

BibTeX
@article{Chaudhuri2026,
  author = {Chaudhuri, Ratan K and Sivamani, Raja K},
  title = {Advancing Epidermal Barrier Resilience in Atopic Dermatitis with Isosorbide Di-Fatty Acid Esters: From Disruption to Restoration},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16091246}
}
Kostenlos starten →